| Nanotechnology as a promising approach to combat multidrug resistant bacteria: a comprehensive review and future perspectives HF Hetta, YN Ramadan, AI Al-Harbi, E A. Ahmed, B Battah, NH Abd Ellah, ... Biomedicines 11 (2), 413, 2023 | 136 | 2023 |
| Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections HF Hetta, YN Ramadan, IMS Al-Kadmy, NHA Ellah, L Shbibe, B Battah Pathogens 12 (8), 1033, 2023 | 13 | 2023 |
| Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis HF Hetta, ZI Rashed, YN Ramadan, IMS Al-Kadmy, SM Kassem, HS Ata, ... Biomedicines 11 (10), 2860, 2023 | 8 | 2023 |
| Quorum sensing inhibitors: an alternative strategy to win the battle against multidrug-resistant (MDR) bacteria HF Hetta, YN Ramadan, ZI Rashed, AA Alharbi, S Alsharef, TT Alkindy, ... Molecules 29 (15), 3466, 2024 | 6 | 2024 |
| Nanotechnology as a promising approach to combat multidrug resistant bacteria: a comprehensive review and future perspectives. Biomedicines 11 (2): 413 HF Hetta, YN Ramadan, AI Al-Harbi, E Ahmed, B Battah, NH Abd Ellah, ... | 5 | 2023 |
| MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease YN Ramadan, AM Kamel, MA Medhat, HF Hetta Clinical and Experimental Medicine 24 (1), 217, 2024 | 4 | 2024 |
| Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review HF Hetta, A Elsaghir, VC Sijercic, MS Akhtar, SA Gad, A Moses, ... Health Science Reports 7 (4), e2036, 2024 | 4 | 2024 |
| Nanotechnology as a promising approach to combat multidrug resistant bacteria: A comprehensive review and future perspectives. Biomedicines 11: 413 HF Hetta, YN Ramadan, AI Al-Harbi, EA Ahmed, B Battah, NH Abd Ellah, ... Molecules 28, 637, 2023 | 4 | 2023 |
| A Ahmed HF Hetta, YN Ramadan, AI Al-Harbi E, 0 | 4 | |
| COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges RM Abd El-Baky, ER Shady, R Yahia, FY Ahmed, M Ramadan, ... AMB Express 13 (1), 99, 2023 | 3 | 2023 |
| Mpox Virus Infection and Vaccination: Immunopathogenesis and Exploring the Link to Neuropsychiatric Manifestations HF Hetta, AA Alharbi, SM Alsharif, TT Alkindy, A Alkhamali, AS Albalawi, ... Immuno 4 (4), 578-600, 2024 | 1 | 2024 |
| Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy HF Hetta, YN Ramadan, AA Alharbi, S Alsharef, TT Alkindy, A Alkhamali, ... Immuno 4 (4), 400-425, 2024 | 1 | 2024 |
| Editorial for Special Issue “Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance” HF Hetta, YN Ramadan, IMS Al-Kadmy Biomedicines 13 (1), 129, 2025 | | 2025 |
| P1045 Treat-smart study: Leveraging individual inflammatory markers for personalized therapy in patients with IBD M Medhat, YN Ramadan, M Hashem, A Doaa, Z Nariman, HF Hetta, ... Journal of Crohn's and Colitis 19 (Supplement_1), i1930-i1930, 2025 | | 2025 |
| Antimicrobial Peptides: The Game-Changer in the Epic Battle Against Multidrug-Resistant Bacteria HF Hetta, N Sirag, SM Alsharif, AA Alharbi, TT Alkindy, A Alkhamali, ... Pharmaceuticals 17 (11), 1555, 2024 | | 2024 |
Helal F HettaUniversity of Tabuk, Tabuk 71491, Saudia Arabiaبريد إلكتروني تم التحقق منه على ut.edu.sa